More Vaccines for Mpox Arrive in Uganda as Regional Response Strengthens

KAMPALA , UGANDA. The Africa Centers for Disease Control and Prevention (Africa CDC), in partnership with global health firms, has boosted vaccine supply for mpox across Africa — with substantial allocations destined for Uganda. The move comes amid heightened alertness to outbreaks in border-communities and aims to ramp up prevention and response capacity.
Health officials say the additional doses will improve readiness in districts experiencing high mobility and limited health infrastructure — settings where mpox spreads fast and containment is harder. The partnership also signals a shift toward more proactive health security planning.
Why it matters:

Uganda, as a hub for regional transport and migration, is particularly vulnerable to disease spill-over and cross-border transmissions.

Timely and equitable vaccine access improves the odds of containing outbreaks before they escalate.

Strengthening surveillance and vaccine logistics in rural and border-areas is key for sustained disease control.
What’s next:

Deploying the vaccines to high-risk zones and integrating them into national outbreak-response plans.

Monitoring vaccine uptake, adverse events, and effect on incidence rates.

Enhancing cross-border health coordination and rapid-response mechanisms.